Alvotech
ALVOW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001898416
No open-market purchases or sales by Alvotech insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $1.16M in total; Oaktree Capital is the only superinvestor holding it.
Other share classesALVO
Q3 2024 vs. Q2 2024
How the institutions holding Alvotech changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 12 | 10 | −2 |
| Shares | 5.27M | 5.18M | −93.3K (−1.8%) |
| Value | $15.8M | $15.7M | −$13.9K (−0.1%) |
New holders (2)
Institutions that held Alvotech at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Clear Street LLC | 400 | $1.05K | 0.00% |
| Bank of America Corp | 200 | $542 | 0.00% |
Sold out (4)
Institutions that held Alvotech at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| FreeGulliver LLC | 43,681 | $130.6K |
| Boussard & Gavaudan Investment Management LLP | 30,000 | $97.5K |
| Kim, LLC | 15,000 | $44.9K |
| Wolverine Asset Management LLC | 2,119 | $6.33K |